Information  X 
Enter a valid email address

Company Name matching 'Curetis'

Date
Time Source
Company
Announcement
12 Aug 2019 6:59 am GNW   Factsheet Curetis (0RDD) Curetis Retains H.C. Wainwright & Co. as Strategic Advisor
08 Aug 2019 6:59 am GNW   Factsheet Curetis (0RDD) Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing
01 Aug 2019 6:58 am GNW   Factsheet Curetis (0RDD) Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes
30 Jul 2019 7:01 am GNW   Factsheet Curetis (0RDD) Curetis and AKO MED Ink Distribution Agreement Covering Four Countries in CEE Region
25 Jul 2019 7:00 am GNW   Factsheet Curetis (0RDD) Curetis to Present at Solebury Trout European Biotech Investor Day in NYC
23 Jul 2019 6:51 am GNW   Factsheet Curetis (0RDD) Curetis Files for U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens
04 Jul 2019 7:02 am GNW   Factsheet Curetis (0RDD) Curetis Group Company Ares Genetics is Granted Key European Patent on Genetic Resistance Testing
02 Jul 2019 7:00 am GNW   Factsheet Curetis (0RDD) Curetis To Attend Key Conferences in the Third Quarter of 2019
28 Jun 2019 6:59 am GNW   Factsheet Curetis (0RDD) Curetis Reports Results of the Annual General Meeting Held on June 27, 2019
04 Jun 2019 7:11 am GNW   Factsheet Curetis (0RDD) New Data on Curetis’ Unyvero LRT Panel for Pneumonia to be Presented at ASM Microbe 2019
23 May 2019 7:00 am GNW   Factsheet Curetis (0RDD) Curetis Reports Positive Results from Clinical Validation Study for U.S. FDA 510(k) Submission of Unyvero LRT for BAL Samples
21 May 2019 5:55 am GNW   Factsheet Curetis (0RDD) Curetis to Receive Additional EUR 6.5 Million Financing from EIB and Yorkville
17 May 2019 6:00 am GNW   Factsheet Curetis (0RDD) Curetis Announces Financial Results for the First Three Months of 2019
15 May 2019 1:00 pm GNW   Factsheet Curetis (0RDD) Curetis to Hold Annual General Shareholders’ Meeting on June 27, 2019
12 Apr 2019 7:00 am GNW   Factsheet Curetis (0RDD) Press release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019
11 Apr 2019 7:01 am GNW   Factsheet Curetis (0RDD) Curetis Publishes Full-Year 2018 Financial Results and Updated Guidance for 2019
05 Apr 2019 7:59 am GNW   Factsheet Curetis (0RDD) Curetis to Publish its Full-Year 2018 Financial Results on April 11, 2019
04 Apr 2019 7:00 am GNW   Factsheet Curetis (0RDD) Curetis: Study Data Presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform
02 Apr 2019 7:04 am GNW   Factsheet Curetis (0RDD) Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance
01 Apr 2019 1:59 pm GNW   Factsheet Curetis (0RDD) Curetis To Attend Key Conferences in the Second Quarter of 2019
26 Mar 2019 7:00 am GNW   Factsheet Curetis (0RDD) Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero
18 Feb 2019 9:05 pm GNW   Factsheet Curetis (0RDD) Curetis’ Subsidiary Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance
04 Feb 2019 6:59 am GNW   Factsheet Curetis (0RDD) Curetis’ Partner Beijing Clear Biotech Submits Filing for Unyvero Approval in China
30 Jan 2019 6:50 am GNW   Factsheet Curetis (0RDD) Curetis’ Unyvero Application Cartridges Receive Regulatory Approvals in Malaysia and Thailand
08 Jan 2019 7:00 am GNW   Factsheet Curetis (0RDD) Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test
18 Dec 2018 7:00 am GNW   Factsheet Curetis (0RDD) Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance
13 Dec 2018 8:04 am GNW   Factsheet Curetis (0RDD) Curetis Sharpens Focus on Near-Term Strategic Value Drivers
23 Nov 2018 6:44 am GNW   Factsheet Curetis (0RDD) Curetis Announces Financial Results for the First Nine Months of 2018
  6:08 am GNW   Factsheet Curetis (0RDD) Curetis Accelerates 510(k) Submission Preparation for Unyvero LRT in BAL Specimen Based on Positive FDA Feedback
07 Nov 2018 5:50 pm GNW   Factsheet Curetis (0RDD) Curetis raises €8.9 million through private placements
02 Nov 2018 7:17 am GNW   Factsheet Curetis (0RDD) Curetis launches privately placed capital increase to raise up to €18.4 million
11 Oct 2018 7:59 am GNW   Factsheet Curetis (0RDD) Curetis, Beijing Clear Biotech Expand Strategic Collaboration for Unyvero in Greater China
02 Oct 2018 7:15 am GNW   Factsheet Curetis (0RDD) Curetis secures financing facility of up to EUR 20 million through the issuance of convertible notes
28 Sep 2018 9:11 am GNW   Factsheet Curetis (0RDD) Curetis Publishes Interim Report for the First Half-Year 2018
17 Sep 2018 6:00 am GNW   Factsheet Curetis (0RDD) Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018
04 Sep 2018 6:01 am GNW   Factsheet Curetis (0RDD) Curetis' Subsidiary Ares Genetics Initiates Development of AI-Powered Infectious Disease Test
14 Aug 2018 6:37 am GNW   Factsheet Curetis (0RDD) Curetis Announces Financial Results for the First Six Months of 2018
  6:01 am GNW   Factsheet Curetis (0RDD) Curetis Announces Change in Curetis USA Inc. Management
07 Aug 2018 8:29 am GNW   Factsheet Curetis (0RDD) Curetis Expands Geographic Presence with Entry into Northern African and Latin American Markets
  7:45 am GNW   Factsheet Curetis (0RDD) Curetis to Report its Half-Year Results 2018 on August 14, 2018
31 Jul 2018 8:30 am GNW   Factsheet Curetis (0RDD) Curetis Subsidiary Ares Genetics Launches ARES & CO Pharma Partnering Program
21 Jun 2018 2:01 pm GNW   Factsheet Curetis (0RDD) Curetis Reports Results of the Annual General Meeting Held on June 21, 2018
12 Jun 2018 6:00 am GNW   Factsheet Curetis (0RDD) Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018
07 Jun 2018 6:01 am GNW   Factsheet Curetis (0RDD) Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S.
18 May 2018 6:01 am GNW   Factsheet Curetis (0RDD) Curetis Publishes Business and Financial Update for the First Quarter 2018
09 May 2018 6:00 am GNW   Factsheet Curetis (0RDD) Curetis to Hold Annual General Shareholders' Meeting on June 21, 2018
30 Apr 2018 6:30 am GNW   Factsheet Curetis (0RDD) Curetis Announces Change of the Composition of Its Supervisory Board
  6:00 am GNW   Factsheet Curetis (0RDD) Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance For 2018
23 Apr 2018 5:59 am GNW   Factsheet Curetis (0RDD) Curetis to Publish its 2017 Annual Results on April 30, 2018
19 Apr 2018 6:00 am GNW   Factsheet Curetis (0RDD) Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018
18 Apr 2018 6:00 am GNW   Factsheet Curetis (0RDD) Curetis: Novel Products and Study Data to be Presented at ECCMID 2018
11 Apr 2018 7:47 am GNW   Factsheet Curetis (0RDD) Curetis Establishes U.S. Scientific Advisory Board
04 Apr 2018 10:33 am GNW   Factsheet Curetis (0RDD) Curetis' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority
  9:05 am GNW   Factsheet Curetis (0RDD) Curetis to Hold Investor Conference Call with Webcast on U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge today
03 Apr 2018 9:45 pm GNW   Factsheet Curetis (0RDD) Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge
26 Mar 2018 7:08 am GNW   Factsheet Curetis (0RDD) Curetis To Attend Key Investor and Scientific Conferences In The Second Quarter 2018
14 Mar 2018 8:09 am GNW   Factsheet Curetis (0RDD) Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology
06 Mar 2018 11:02 am GNW   Factsheet Curetis (0RDD) Curetis subsidiary Ares Genetics wins incubator stay in Silicon Valley
06 Feb 2018 6:05 pm GNW   Factsheet Curetis (0RDD) Curetis Unyvero HPN Application Receives Singapore Health Sciences Authority Approval; Updates on Sepsis Host Response Test
05 Feb 2018 6:10 pm GNW   Factsheet Curetis (0RDD) Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t